Search results
Results From The WOW.Com Content Network
August 1, 2024 at 2:31 PM. Moderna ( MRNA) shares slid more than 20% Thursday after the company slashed its sales guidance for 2024, largely because of a lack of new COVID-19 vaccine orders from ...
Moderna's mRNA platform now features a long list of candidates, and the biotech still has enough cash on hand -- $12.2 billion as of the end of the first quarter -- to fund its programs despite a ...
Moderna has struggled to maintain Wall Street's attention on its pipeline as it recovers from the COVID vaccine highs of 2022, when sales topped $19 billion. But CEO Stéphane Bancel told Yahoo ...
The company's stock was trading slightly up on the news early Monday before falling after market open. Moderna is up almost 20% in the last month after the company received approval from the FDA ...
On Thursday, Moderna Inc (NASDAQ:MRNA) stock plunged as the company lowered its 2024 sales guidance due to weaker demand for its COVID-19 vaccines. Moderna now projects 2024 net sales of between ...
For premium support please call: 800-290-4726 more ways to reach us
Moderna Current Valuation and Performance. Moderna stock sits at $146.36 per share as of Feb. 17, 2022. Depending on which analyst you believe, you should expect either a loss of 42% or gains of ...
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The ...